This 10 Year Trend dashboard displays individual cancer sites age-adjusted rates by race and sex in Virginia from 2011 to 2020. Use the “Trend Indicator” control to select either "Incidence" or "Mortality". Select the “Cancer Site”, “Sex”, and “Race” controls to filter further. You may select more than one cancer site for comparison. You can hover over a line on the graph to view details including the rate.
Declines in cancer incidence between 2019-2020 should be interpreted with caution due to potential impacts on cancer diagnosis from the COVID-19 pandemic.
* Rates and counts have been suppressed if counts are below 16, and will not display.
* Sex-specific cancer sites only reflect data from that population, i.e. female breast staging percentages only include female population data.
Incidence Data
Data Source: Cancer incidence data come from the Virginia Cancer Registry 1995-2021. The counts and rates are generated using Surveillance, Epidemiology, and End Results (SEER)*STAT software.
Population Estimates: Population estimates are obtained from SEER*Stat Database: Populations - Total U.S. (1969-2022), released March 2024. The National Cancer Institute (NCI) procures and maintains U.S. population data for the denominators of cancer incidence rates.
Age-adjusted Rates: Age-adjusted rates are presented as hospitalizations per 100,000 population. Incidence rates are adjusted (weighted) to the proportion of persons in each age group. The standard age-distribution of the U.S. population in 2000 is used to calculate age-adjusted rates. The benefit of age-adjusted rates compared with unadjusted (crude) rates is it allows for comparisons across groups (geography, ethnicity, race, and sex) of different age compositions.
Race: Only two races are presented in the data, Black and White. The Virginia Cancer Registry is working on improving race/ethnicity
Definitions:
- All Sites: includes all malignant cancers and urinary bladder cancer
- Brain and Other Nervous System: tumors in the brain and spinal cord
- Cervix Uteri: cancer that develops in the cervix, the lower part of the uterus that connects to the vagina
- Colorectal: a type of cancer that develops in the colon or rectum. It includes cecum, appendix, ascending colon, hepatic flexure, transverse colon, splenic flexure, descending colon, sigmoid colon, large intestine (not otherwise specified), rectosigmoid junction, and rectum
- Corpus and Uterus, not otherwise specified (NOS): cancer of the body of the uterus
- Esophagus: cancer that develops in the esophagus
- Female Breast: cancer that develops in the breast tissue
- Hodgkin Lymphoma: a type of cancer that affects the lymphatic system and it includes Hodgkin-nodal and Hodgkin-extra nodal
- Kidney and Renal Pelvis: cancer that develops in the kidney or renal pelvis
- Leukemia: cancer of the body's blood-forming tissues and it includes acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia, other lymphocytic leukemia, acute myeloid leukemia (AML), acute monocytic leukemia, chronic myeloid leukemia, other myeloid/monocytic leukemia, other acute leukemia, aleukemic, subleukemic and not otherwise specified
- Liver and Intrahepatic Bile Duct: cancer that forms in the bile ducts within the liver.
- Lung & Bronchus: cancer that starts in the lungs or the airways (bronchi) that lead to the lungs
- Melanoma of the Skin: skin cancer that develops in melanocytes
- Myeloma: type of blood cancer that develops from plasma cells in the bone marrow
- Non-Hodgkin Lymphoma (NHL): cancer that originates in the lymphatic system. Includes NHL-Nodal and NHL-Extra Nodal.
- Oral Cavity & Pharynx: type of head and neck cancer that affects the mouth and throat. It includes lip, tongue, salivary gland, floor of mouth, gum and other mouth, nasopharynx, tonsil, oropharynx, hypopharynx, and other oral cavity & pharynx
- Ovary: cancer that develops in the ovaries, fallopian tubes, or peritoneum (the lining of the abdominal cavity)
- Pancreas: cancer that develops in the pancreas
- Prostate: cancer that develops in the prostate gland
- Stomach: cancer that arises in the stomach lining
- Thyroid: cancer that develops in the thyroid gland
- Urinary Bladder: cancer that develops in the cells lining the bladder
Other: Data are produced and processed from sources believed to be reliable and accurate at that point of time. Unknown/Unreported variables were removed from the tables. Counts and rates based on cases fewer than 16 are not shown in accordance with suppression rules by the US Cancer Statistics, Centers for Disease Control and Prevention.
Death Data
Data Source: Cancer death (mortality) data are obtained from the SEER*Stat Database. Death data are collected and maintained by the National Center for Health Statistics (NCHS), and are analyzed with the SEER*Stat software. Deaths are reported by the Virginia city or county where the decedent normally resided at the time of death, regardless of where the death occurred.
Population Estimates: Population estimates are obtained from SEER*Stat Database: Populations - Total U.S. (1969-2022), released March 2024. The National Cancer Institute (NCI) procures and maintains U.S. population data for the denominators of cancer incidence rates.
Age-adjusted Rates: Age-adjusted death rates are presented as deaths per 100,000 population. Death rates are adjusted (weighted) to the proportion of persons in each age group. The standard age-distribution of the U.S. population in 2000 is used to calculate age-adjusted rates. The benefit of age-adjusted rates compared with unadjusted (crude) rates is it allows for comparisons across groups (geography, ethnicity, race, and sex) of different age compositions.
Causes of Death: International Classification of Diseases, Tenth Revision (ICD-10) medical coding are used to report underlying cause of death codes for malignant neoplasms, C00-C97.
Race: Only two races are presented in the data, Black and White. The Virginia Cancer Registry is working on improving race/ethnicity classifications.
Other: Data are produced and processed from sources believed to be reliable and accurate at that point of time. Unknown/Unreported variables were removed from the tables. Counts and rates based on cases fewer than 16 are not shown in accordance with suppression rules by the US Cancer Statistics, Centers for Disease Control and Prevention.